Gopi Ranganna is currently Associate Vice president, Global Clinical Development at Viatris, based in India. In this role, he provides strategic clinical leadership and plans, designs, and oversees the biosimilar clinical studies across multiple therapy areas. Before joining Viatris, he has worked on novel product development and patient safety at AstraZeneca and UCB pharma. He is a physician by training and has Masters in Experimental Therapeutics from the University of Oxford and is a Fellow of the Faculty of Pharmaceutical Medicine (UK).